<DOC>
	<DOC>NCT02796118</DOC>
	<brief_summary>The objective of this study is to evaluate the safety and the pharmacokinetics of ASP2151 after multiple oral dosing of ASP2151 in healthy non-elderly male and elderly male Japanese subjects, and to compare the pharmacokinetics of ASP2151 in healthy non-elderly male and elderly male Japanese subjects.</brief_summary>
	<brief_title>Study to Evaluate the Safety and Pharmacokinetics of ASP2151 in Healthy Non-elderly and Elderly Subjects</brief_title>
	<detailed_description />
	<criteria>Body weight: ≥50.0 kg and &lt;85.0 kg Body mass index (BMI): ≥17.6 and &lt;26.4 kg/m2 Subjects with a complication of any diseases Subjects with a history of hepatic disease Subjects with a history of heart disease Subjects with a history of respiratory disease Subjects with a history of alimentary disease Subjects with a history of renal disease Subjects with a history of cerebrovascular disorder Subjects with a history of malignant tumor Subjects with a history of drug allergies or allergies disorders excluding pollinosis Subjects with a history of drug dependency or alcohol dependence syndrome Subjects who developed genital herpes or herpes zoster within 90 days before the initial dosing Subjects who do not meet any of the criteria for laboratory tests Subjects who received medications within 14 days before the initial dosing. Subjects who received any investigational drugs in other clinical trials or postmarketing studies within 120 days before screening or the initial dosing Excessive alcohol drinking or smoking habit Subjects who previously received administration of ASP2151 (including placebo) Abnormalities detected on an ophthalmological examination Subjects who deviate from the normal range of standard 12lead ECG at screening</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Healthy non-elderly and elderly subjects</keyword>
	<keyword>ASP2151</keyword>
	<keyword>Safety</keyword>
</DOC>